Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
53.57
+1.86 (3.60%)
At close: Feb 27, 2026, 4:00 PM EST
53.68
+0.11 (0.21%)
After-hours: Feb 27, 2026, 7:59 PM EST

Moderna Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
21,15711,52316,00137,91969,006102,976
Market Cap Growth
80.05%-27.99%-57.80%-45.05%-32.99%149.10%
Enterprise Value
14,3275,6108,15426,52853,26494,653
Last Close Price
53.5729.4941.5899.45179.62253.98
PE Ratio
----8.258.44
Forward PE
----37.048.08
PS Ratio
10.885.934.955.543.585.58
PB Ratio
2.441.331.472.743.617.28
P/TBV Ratio
2.471.351.482.763.617.28
P/FCF Ratio
----15.067.72
P/OCF Ratio
----13.857.56
EV/Sales Ratio
7.372.892.523.872.775.12
EV/EBITDA Ratio
----5.457.00
EV/EBIT Ratio
----5.657.12
EV/FCF Ratio
----11.637.10
Debt / Equity Ratio
0.150.150.070.090.060.07
Debt / EBITDA Ratio
----0.120.07
Debt / FCF Ratio
----0.260.07
Net Debt / Equity Ratio
-0.79-0.79-0.80-0.87-0.89-1.18
Net Debt / EBITDA Ratio
2.392.392.343.33-1.74-1.23
Net Debt / FCF Ratio
3.313.312.163.15-3.71-1.25
Asset Turnover
0.150.150.200.310.761.15
Inventory Turnover
29.6329.6337.6613.926.025.19
Quick Ratio
3.063.063.453.212.351.54
Current Ratio
3.293.293.673.432.731.76
Return on Equity (ROE)
-28.87%-28.87%-28.77%-28.59%50.27%146.08%
Return on Assets (ROA)
-14.51%-14.51%-15.14%-11.96%23.30%51.93%
Return on Invested Capital (ROIC)
-63.28%-70.03%-70.98%-50.12%111.51%967.68%
Return on Capital Employed (ROCE)
-29.70%-29.70%-33.10%-27.50%45.00%85.60%
Earnings Yield
-13.34%-24.49%-22.25%-12.43%12.12%11.85%
FCF Yield
-9.76%-17.92%-25.34%-10.09%6.64%12.95%
Buyback Yield / Dilution
-1.30%-1.30%-0.52%8.17%3.48%-13.12%
Updated Feb 13, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q